Clinical trial
Hepatocellular Carcinoma Treated With Radiofrequency Ablation With or Without Iodine-125 Implantation: A Prospective Study
NCT01717729 is registered in ClinicalTrials.gov with The Second People's Hospital of GuangDong Province as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hepatocellular Carcinoma Treated With Radiofrequency Ablation With or Without Iodine-125 Implantation: A Prospective Study
- Lead sponsor
- The Second People's Hospital of GuangDong Province
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2000
- Completion date
- October 31, 2012
- Enrollment
- 136 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
liver carcinoma